…
Science to Consumers, Inc., a development stage company, focuses on marketing and selling formulated anti-aging cream products under the DermaLastyl name; and distributing Argan oil products. It intends to sell its products to individual customers and commercial customers, such as spas, stores, and massage therapy offices. The company was formerly known as Argan Beauty Corporation and changed its name to Science to Consumers, Inc. in December 2014. Science to Consumers, Inc. was founded in 2013 and is based in Guangzhou, China.
Source: TradingView
The charts and visual representations are sourced from TradingView through embedded widgets. For any issues with chart display, please visit the TradingView website
A unique technical analysis driven score developed by Kalkine showing momentum in stock prices based on select technical indicators identified.
| Breakdown | 2016-05-31 | 2015-05-31 | 2014-05-31 | 2013-05-31 |
|---|---|---|---|---|
| Type | yearly | yearly | yearly | yearly |
| Date | 2016-05-31 | 2015-05-31 | 2014-05-31 | 2013-05-31 |
| Income before tax | -0.06M | -0.05M | -0.03M | -0.00M |
| Minority interest | 0.00M | 0.00M | 0.00M | 0.00M |
| Net income | -0.06M | -0.05M | -0.03M | -0.00M |
| Selling general administrative | 0.05M | 0.05M | 0.03M | 0.03M |
| Selling and marketing expenses | 0.01M | 0.00M | 0.00M | - |
| Gross profit | 0.00M | 0.00M | 0.00M | -0.00M |
| Ebit | -0.06M | -0.05M | -0.03M | -0.00M |
| Ebitda | -0.06M | -0.05M | -0.03M | - |
| Depreciation and amortization | 0.00M | 0.00M | 0.00M | - |
| Non operating income net other | 0.00M | 0.00M | 0.00M | 0.00M |
| Operating income | -0.06M | -0.05M | -0.03M | -0.00M |
| Other operating expenses | 0.06M | 0.05M | 0.03M | 0.00M |
| Interest expense | 0.00M | 0.00M | 0.00M | 0.00M |
| Tax provision | 0.00M | - | - | - |
| Net interest income | -0.00M | - | - | - |
| Extraordinary items | 0.00M | 0.00M | 0.00M | 0.00M |
| Non recurring | 0.00M | 0.00M | 0.00M | 0.00M |
| Other items | 0.00M | 0.00M | 0.00M | 0.00M |
| Income tax expense | 0.00M | 0.00M | 0.00M | 0.00M |
| Total revenue | 0.00M | 0.00M | 0.00M | 0.00M |
| Total operating expenses | 0.06M | 0.05M | 0.03M | 0.00M |
| Cost of revenue | 0.00M | 0.00M | 0.00M | 0.00M |
| Total other income expense net | -0.00M | 0.00M | 0.00M | -0.00M |
| Discontinued operations | 0.00M | 0.00M | 0.00M | 0.00M |
| Net income from continuing ops | -0.06M | -0.05M | -0.03M | -0.00M |
| Net income applicable to common shares | -0.06M | -0.05M | -0.03M | -0.00M |
| Preferred stock and other adjustments | 0.00M | 0.00M | 0.00M | 0.00M |
| Breakdown | 2016-05-31 | 2015-05-31 | 2014-05-31 | 2013-05-31 |
|---|---|---|---|---|
| Type | yearly | yearly | yearly | yearly |
| Date | 2016-05-31 | 2015-05-31 | 2014-05-31 | 2013-05-31 |
| Total assets | 0.01M | 0.00M | 0.01M | 0.00M |
| Intangible assets | 0.01M | 0.00M | 0.00M | 0.00M |
| Other current assets | 0.00M | 0.00M | 0.00M | 0.00M |
| Total liab | 0.06M | 0.01M | 0.01M | 0.00M |
| Total stockholder equity | -0.05M | -0.01M | -0.00M | 0.00M |
| Deferred long term liab | 0.00M | 0.00M | 0.00M | 0.00M |
| Other current liab | 0.01M | 0.00M | 0.00M | 0.00M |
| Common stock | 0.03M | 0.03M | 0.03M | 0.02M |
| Retained earnings | -0.16M | -0.10M | -0.05M | -0.02M |
| Other liab | 0.00M | 0.00M | 0.00M | 0.00M |
| Good will | 0.00M | 0.00M | 0.00M | 0.00M |
| Other assets | 0.00M | 0.00M | 0.00M | 0.00M |
| Cash | 0.00M | 0.00M | 0.01M | 0.00M |
| Total current liabilities | 0.06M | 0.01M | 0.01M | 0.00M |
| Net debt | 0.04M | -0.00M | -0.01M | -0.00M |
| Short term debt | 0.04M | 0.00M | 0.00M | 0.00M |
| Short long term debt | 0.04M | 0.01M | 0.01M | 0.00M |
| Short long term debt total | 0.04M | - | - | - |
| Other stockholder equity | 0.07M | 0.06M | 0.02M | 0.00M |
| Property plant equipment | 0.00M | 0.00M | 0.00M | 0.00M |
| Total current assets | 0.00M | 0.00M | 0.01M | 0.00M |
| Long term investments | 0.00M | 0.00M | 0.00M | 0.00M |
| Net tangible assets | -0.06M | -0.01M | -0.00M | 0.00M |
| Short term investments | 0.00M | 0.00M | 0.00M | 0.00M |
| Long term debt | 0.00M | 0.00M | 0.00M | 0.00M |
| Inventory | 0.00M | 0.00M | 0.00M | 0.00M |
| Accounts payable | 0.02M | 0.01M | 0.01M | 0.00M |
| Total permanent equity | 0.00M | 0.00M | 0.00M | 0.00M |
| Noncontrolling interest in consolidated entity | 0.00M | 0.00M | 0.00M | 0.00M |
| Temporary equity redeemable noncontrolling interests | 0.00M | 0.00M | 0.00M | 0.00M |
| Accumulated other comprehensive income | 0.00M | 0.00M | 0.00M | 0.00M |
| Additional paid in capital | 0.00M | 0.00M | 0.00M | 0.00M |
| Common stock total equity | 0.00M | 0.00M | 0.00M | 0.00M |
| Preferred stock total equity | 0.00M | 0.00M | 0.00M | 0.00M |
| Retained earnings total equity | 0.00M | 0.00M | 0.00M | 0.00M |
| Treasury stock | 0.00M | 0.00M | 0.00M | 0.00M |
| Accumulated amortization | 0.00M | 0.00M | 0.00M | 0.00M |
| Non currrent assets other | 0.01M | 0.00M | 0.00M | 0.00M |
| Deferred long term asset charges | 0.00M | 0.00M | 0.00M | 0.00M |
| Non current assets total | 0.01M | 0.00M | 0.00M | 0.00M |
| Capital lease obligations | 0.00M | 0.00M | 0.00M | 0.00M |
| Long term debt total | 0.00M | 0.00M | 0.00M | 0.00M |
| Breakdown | 2016-05-31 | 2015-05-31 | 2014-05-31 | 2013-05-31 |
|---|---|---|---|---|
| Type | yearly | yearly | yearly | yearly |
| Date | 2016-05-31 | 2015-05-31 | 2014-05-31 | 2013-05-31 |
| Investments | 0.00M | 0.00M | 0.00M | 0.00M |
| Change to liabilities | 0.01M | 0.00M | 0.00M | 0.00M |
| Total cashflows from investing activities | 0.00M | 0.00M | 0.00M | 0.00M |
| Net borrowings | 0.04M | 0.00M | 0.01M | 0.00M |
| Total cash from financing activities | 0.05M | 0.05M | 0.03M | 0.02M |
| Change to operating activities | 0.00M | 0.00M | 0.00M | 0.00M |
| Net income | -0.06M | -0.05M | -0.03M | -0.00M |
| Change in cash | 0.00M | -0.00M | 0.00M | 0.02M |
| Begin period cash flow | 0.00M | 0.01M | 0.00M | - |
| End period cash flow | 0.00M | 0.00M | 0.01M | 0.00M |
| Total cash from operating activities | -0.05M | -0.05M | -0.03M | -0.00M |
| Depreciation | 0.00M | 0.00M | 0.00M | 0.00M |
| Other cashflows from investing activities | 0.00M | 0.00M | 0.00M | 0.00M |
| Dividends paid | 0.00M | 0.00M | 0.00M | 0.00M |
| Change to inventory | 0.00M | 0.00M | 0.00M | 0.00M |
| Change to account receivables | 0.00M | 0.00M | 0.00M | 0.00M |
| Sale purchase of stock | 0.01M | 0.03M | 0.02M | 0.02M |
| Other cashflows from financing activities | 0.05M | 0.00M | 0.01M | 0.00M |
| Change to netincome | 0.00M | 0.00M | 0.00M | 0.00M |
| Capital expenditures | 0.00M | 0.00M | 0.00M | 0.00M |
| Change receivables | 0.00M | 0.00M | 0.00M | 0.00M |
| Cash flows other operating | 0.00M | 0.00M | 0.00M | 0.00M |
| Exchange rate changes | 0.00M | 0.00M | 0.00M | 0.00M |
| Cash and cash equivalents changes | 0.00M | 0.00M | 0.00M | 0.00M |
| Change in working capital | 0.01M | - | - | - |
| Free cash flow | -0.05M | -0.05M | -0.03M | - |
Sector: Consumer Defensive Industry: Household & Personal Products
|
Stock Name
|
Change
(USD) |
Price
(USD) |
Trailing
PE (x) |
Forward
PE (x) |
Price Sales
TTM (x) |
Price to Book Value (x)
|
Enterprise Value
to EBITDA (x) |
|---|---|---|---|---|---|---|---|
| PG Procter & Gamble Company |
-0.17 0.10% |
169.37 | 23.58 | 22.62 | 4.07 | 7.24 | 16.08 |
| LRLCF L'Oréal S.A |
- -% |
472.30 | 41.14 | 34.25 | 6.52 | 8.59 | 27.76 |
| LRLCY L’Oreal Co ADR |
-1.24 1.30% |
94.49 | 32.44 | 25.64 | 5.16 | 6.03 | 19.51 |
| UL Unilever PLC ADR |
0.49 0.77% |
63.85 | 21.53 | 16.39 | 2.66 | 7.29 | 12.45 |
Science to Consumers, Inc., a development stage company, focuses on marketing and selling formulated anti-aging cream products under the DermaLastyl name; and distributing Argan oil products. It intends to sell its products to individual customers and commercial customers, such as spas, stores, and massage therapy offices. The company was formerly known as Argan Beauty Corporation and changed its name to Science to Consumers, Inc. in December 2014. Science to Consumers, Inc. was founded in 2013 and is based in Guangzhou, China.
American Bank Centre, Guangzhou, China
86 139 0225 5701
1
| Name | Title | Year Born |
|---|---|---|
| Mr. Vitaliy Gorelik | Chairman, Pres, Chief Financial Officer, Treasurer and Controller | 1976 |
| Mr. Ensley Edwon Lam | Chief Exec. Officer | 1958 |
| Dr. Burt D. Ensley | Advisor | 1949 |
| Ms. Caroline Bastidas | Sec. | 1982 |
Disclaimer - (*)This information, including any data, is sourced from Unicorn Data Services SAS, trading as EOD Historical Data (“EODHD”) on an ‘as is’ basis, using their API. We cannot guarantee the completeness or validity of the information and data provided on this page, as well as via the API. In some cases, the data may include analyst ratings or recommendations sourced through the EODHD API, which are intended solely for general information purposes.
This information does not consider your personal objectives, financial situation, or needs. Kalkine is not liable for any errors or omissions in the information provided or for any actions taken in reliance on it. You should seek advice from a financial adviser, stockbroker or other professional adviser (including taxation and legal advice) as necessary before acting on this information.